EXECUTIVE SUMMARY:
This final report identifies the results of our review of the reporting of Medicaid drug data by pharmacists to the State Medicaid agencies (States). We sent a questionnaire to the 50 States and the District of Columbia, and 46 states responded. Our review disclosed that 22 of the 46 States, or about 48 percent, indicated problems in reporting accurate drug utilization data for use by the manufacturers in determining rebate payments.